NGS Workflows and Technology Advances in Lung Cancer Practice

Here the experts discuss how next generation sequencing is transforming lung cancer testing workflows, particularly in community settings. They describe the challenges of interpreting large genomic reports and the need for support systems such as molecular tumor boards and decision support tools.
The panel also highlights key technological improvements, including faster turnaround times, broader panels, and improved sensitivity, which allow clinicians to identify actionable alterations more quickly and reliably. These advances are making precision oncology more accessible across different practice environments and helping ensure that more lung cancer patients receive appropriate targeted therapies.